Artois-Baillet Latour Foundation

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The Artois-Baillet Latour Foundation is a Belgian non-profit organization which was founded on 1 March 1974.


The 2013 prize is given by The Queen of the Belgians to Carlo M. Croce

The foundation was born by the initiative of Count Alfred de Baillet Latour, who was the Director of the Artois Breweries in Leuven, Belgium. He was the last male heir of the old House of Baillet, and was by motherside related to the House of Spoelberch, who own the Artois Company. In 1995 the name was changed in Interbrew-Baillet Latour Foundation and in 2005, the name was changed to InBev-Baillet Latour Fund.

The Foundation wants to encourage and reward achievements of outstanding human value in the Arts and Sciences. It can do this by means of Prizes, or by any other means that the Foundation might deem appropriate.

Artois-Baillet Latour Health Prize[edit]

The Artois-Baillet Latour Health Prize was established in 1977 to be awarded periodically to recognize the merits of a person whose work has contributed prominently to the improvement of human health in the fields of metabolic disorders, infectious diseases, neurological diseases, cancer and cardiovascular disease. Since 2000 the prize has been awarded annually. Worth 250,000 euros, it is Belgium's major scientific prize.

Health Prize Laureates[edit]

Source: Fund for Scientific Research-FNRS (Belgium)

1979 Sir James W. Black, Great Britain
1981 Sir Cyril A. Clarke, Great Britain
1983 Professor Jean Bernard, France
1985 Professor Johannes J. van Rood, the Netherlands
1987 Professors Viktor Mutt and Tomas Hökfelt (Karolinska Institute, Stockholm, Sweden)
1989 Professor Walter Fiers, University of Ghent, Belgium
1991 Professor Thomas Waldmann, National Cancer Institute, Bethesda, United States of America
1993 Professor Jean-François Borel, University of Bern, Switzerland
1995 Professor Roger Tsien, University of California, San Diego, United States of America
1997 Professor Michael Sela, Weizmann Institute of Science, Rehovot, Israel.
1999 Professor Julien Mendlewicz of the Université Libre de Bruxelles, Brussels, Belgium
2000 Professors Jacques Van Snick and Jean-Christophe Renauld, Ludwig Institute for Cancer Research, Université Catholique de Louvain, Belgium
2001 Dr Jan Van Embden, Laboratory for Infectious Diseases, Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, the Netherlands
2002 Professor Robert M. Krug, Austin, United States of America
2003 Professor Nancy C. Andreasen, Iowa City, United States of America
2004 Professor Elio Lugaresi, Bologna, Italy
2005 Professors Désiré Collen and Peter Carmeliet, Katholieke Universiteit Leuven and the VIB, Belgium
2006 Professor Hidde Ploegh, Whitehead Institute, Massachusetts Institute of Technology (MIT), United States of America
2007 Professor Peter H. Seeburg, Max-Planck-Institute for Medical Research, Heidelberg, Germany
2008 Professor Robert A. Weinberg, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, United States of America
2009 Professor Kari Alitalo, University of Helsinki and Professor Seppo Ylä-Herituala, University of Kuopio
2010 Professor Stephen O'Rahilly, University of Cambridge
2011 Professor Jean-Laurent Casanova, Rockefeller University (infectious diseases)
2012 Professor Gero Miesenböck, University of Oxford (neurological disorders)
2013 Professor Carlo M. Croce, Ohio State University (cancer)
2014 Professor Harry C. Dietz, Johns Hopkins University (cardiovascular disease)
2015 Professor Bruce Spiegelman, Harvard Medical School (metabolic disorders)
2016 Charles M. Rice, USA (infectious diseases)
2017 Adriano Aguzzi, Switzerland (neurological disorders)
2018 (cancer)

See also[edit]

External links[edit]